Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Purwiga A"'
Publikováno v:
In Clinical Epidemiology and Global Health October-December 2021 12
Autor:
Wijaya, Indra, Andhika, Rizky, Huang, Ian, Purwiga, Aga, Budiman, Kevin Yonatan, Bashari, Muhammad Hasan, Reniarti, Lelani, Roesli, Rully Marsis Amirullah
Publikováno v:
In Clinical Epidemiology and Global Health July-September 2021 11
Autor:
Soeroto, Arto Yuwono, Soetedjo, Nanny Natalia, Purwiga, Aga, Santoso, Prayudi, Kulsum, Iceu Dimas, Suryadinata, Hendarsyah, Ferdian, Ferdy
Publikováno v:
In Diabetes & Metabolic Syndrome: Clinical Research & Reviews November-December 2020 14(6):1897-1904
Autor:
Arto Yuwono Soeroto, Raden Desy Nurhayati, Aga Purwiga, Bony Wiem Lestari, Chica Pratiwi, Prayudi Santoso, Iceu Dimas Kulsum, Hendarsyah Suryadinata, Ferdy Ferdian
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0263304 (2022)
Background and aimsMulti drug or rifampicin resistant tuberculosis (MDR/RR-TB) is a major burden to TB prevention and eradication globally. Since 2016, WHO guidelines have included options for treating MDR/RR-TB with a standard regimen of 9 to 11 mon
Externí odkaz:
https://doaj.org/article/15d3662fb48b4b89ac04e2967ca70e6b
Publikováno v:
Clinical Epidemiology and Global Health, Vol 12, Iss , Pp 100883- (2021)
Background: Repurposing the use of aspirin to treat hospitalized patients with COVID-19 is a sensible approach. However, several previous studies showed conflicting results. This meta-analysis was aimed to assess the effect of aspirin on the outcome
Externí odkaz:
https://doaj.org/article/f4679aaf817945758256ea4fcab349d6
Autor:
Indra Wijaya, Rizky Andhika, Ian Huang, Aga Purwiga, Kevin Yonatan Budiman, Muhammad Hasan Bashari, Lelani Reniarti, Rully Marsis Amirullah Roesli
Publikováno v:
Clinical Epidemiology and Global Health, Vol 11, Iss , Pp 100755- (2021)
Background: The evidence of using JAK inhibitors among hospitalized patients with COVID-19 is conflicting. The systematic review and meta-analysis aimed to address the efficacy of Janus Kinase (JAK) Inhibitors in reducing risk of mortality among hosp
Externí odkaz:
https://doaj.org/article/db941a6fafb24ad6baf8428a14750f23
Autor:
Teddy Arnold Sihite, Nanny N M Soetedjo, Hikmat Permana, Aga Purwiga, Rudi Wisaksana, Nuraini Yasmin Kusumawardhani, Erwan Martanto, Ian Huang
Publikováno v:
Pharmacological Reports
Background and aims The idea of treating COVID-19 with statins is biologically plausible, although it is still controversial. The systematic review and meta-analysis aimed to address the association between the use of statins and risk of mortality in
Autor:
Hendarsyah Suryadinata, Aga Purwiga, Ferdy Ferdian, Arto Yuwono Soeroto, Iceu Dimas Kulsum, Prayudi Santoso, Nanny N M Soetedjo
Publikováno v:
Diabetes & Metabolic Syndrome
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Background and aims Corona virus diseases 2019 (COVID-19) pandemic spread rapidly. Growing evidences that overweight and obesity which extent nearly a third of the world population were associated with severe COVID-19. This study aimed to explore the
Publikováno v:
European review for medical and pharmacological sciences. 25(14)
To investigate the role of Convalescent Plasma (CP) in reducing mortality of COVID-19 patients.A systematic literature search was conducted from PubMed, Embase, Medrxiv, and Google Scholar from April and finalized in December 2020 using the following
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.